Literature DB >> 7796134

Angiotensin II receptor subtypes in the human central nervous system.

D P MacGregor1, C Murone, K Song, A M Allen, G Paxinos, F A Mendelsohn.   

Abstract

The distribution of the AT1 and AT2 subtypes of angiotensin II receptor was mapped in the adult human central nervous system using quantitative in vitro autoradiography. Binding in all forebrain, midbrain, pontine, medullary and spinal cord sites where angiotensin II receptors have previously been described is of the AT1 subtype, as is binding in the small and large arteries in the adjacent meninges and in choroid plexus. By contrast, both AT1 and AT2 receptors occur in the molecular layer of the cerebellum. Angiotensin II AT1 receptors in the brain show a moderate degree of conservation across mammalian species studied so far, whereas expression of AT2 receptors is more variable, and is more restricted in the human CNS than in many other mammals. These differences between the subtype distributions in humans and other animals indicate the need for care when extrapolating the results of animal studies involving the brain angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796134     DOI: 10.1016/0006-8993(95)00076-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides.

Authors:  Vardan T Karamyan; Craig A Stockmeier; Robert C Speth
Journal:  Life Sci       Date:  2008-07-22       Impact factor: 5.037

2.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

Review 3.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

4.  Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions.

Authors:  Colin Sumners; Amy Alleyne; Vermalí Rodríguez; David J Pioquinto; Jacob A Ludin; Shormista Kar; Zachary Winder; Yuma Ortiz; Meng Liu; Eric G Krause; Annette D de Kloet
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

5.  An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II.

Authors:  Vien H Y Lee; Leo T O Lee; Jessica Y S Chu; Ian P Y Lam; Francis K Y Siu; Hubert Vaudry; Billy K C Chow
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

6.  The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans.

Authors:  Thomas F Newton; Richard De La Garza; Ken Grasing
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

7.  Activation of the renin-angiotensin system, specifically in the subfornical organ is sufficient to induce fluid intake.

Authors:  Jeffrey P Coble; Martin D Cassell; Deborah R Davis; Justin L Grobe; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-25       Impact factor: 3.619

8.  Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors.

Authors:  Andrea Linares; Leena E Couling; Eduardo J Carrera; Robert C Speth
Journal:  J Vis Exp       Date:  2016-06-07       Impact factor: 1.355

9.  Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat.

Authors:  Jaroslav Pavel; Hui Tang; Stephen Brimijoin; Armen Moughamian; Tsuyoshi Nishioku; Julius Benicky; Juan M Saavedra
Journal:  Brain Res       Date:  2008-10-17       Impact factor: 3.252

10.  Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.

Authors:  D C Brown; L J Steward; J Ge; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.